Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Receivables (2022 - 2025)

Core Laboratories (CLB) has 4 years of Receivables data on record, last reported at $111.4 million in Q3 2025.

  • For Q3 2025, Receivables fell 5.72% year-over-year to $111.4 million; the TTM value through Sep 2025 reached $111.4 million, down 5.72%, while the annual FY2024 figure was $112.1 million, 1.34% up from the prior year.
  • Receivables reached $111.4 million in Q3 2025 per CLB's latest filing, down from $114.2 million in the prior quarter.
  • Across five years, Receivables topped out at $118.2 million in Q3 2024 and bottomed at $105.2 million in Q3 2023.
  • Average Receivables over 4 years is $112.5 million, with a median of $112.1 million recorded in 2024.
  • Peak YoY movement for Receivables: grew 12.35% in 2024, then decreased 5.72% in 2025.
  • A 4-year view of Receivables shows it stood at $108.1 million in 2022, then increased by 2.39% to $110.6 million in 2023, then rose by 1.34% to $112.1 million in 2024, then decreased by 0.63% to $111.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $111.4 million in Q3 2025, $114.2 million in Q2 2025, and $117.8 million in Q1 2025.